Tag: United States Patent and Trademark Office
May 20, 2018
Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 10, 2018
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of... May 7, 2018
International Stem Cell Corporation Granted Key Patent in US
International Stem Cell Corporation (OTCQB:ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that...
April 29, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... April 27, 2018
Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 16, 2018
Mastercard Turns to Blockchain for Cracking Down on Fake IDs
The credit card company filed a blockchain patent solution to protect identity data with the US Patent and Trademark Office... April 13, 2018
Cannabis Weekly Round-Up: John Boehner Joins the Cannabis Industry
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... April 11, 2018
EyeGate Issued New Patent for Iontophoretic Contact Lens Technology
EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the...
April 11, 2018
Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for Cannabinoid Delivery and Updates its Expanding Patent Portfolio
Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the...
March 27, 2018
